WaferGen Bio News Breakdown

WGBS -- USA Stock  

USD 6.90  0.00  0.00%

Macroaxis does not monitor all media channels or aggregates social signals for WaferGen Bio. But even though we do not provide professional-grade financial sentiment analysis on WaferGen Bio systems, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for WaferGen Bio. See also WaferGen Bio Hype Analysis, WaferGen Bio Correlation and WaferGen Bio Performance.
  
few days ago at www.macroaxis.com         
WaferGen Bio exotic insider transaction detected
Macroaxis News
Filed transaction by Wafergen Biosystems Inc director. Unconventional Insider trading
  
  
few days ago at www.macroaxis.com         
Acquisition by Makoto Kaneshiro of 20000 shares of WaferGen Bio subject to Rule 16b-3
Macroaxis News
Filed transaction by Wafergen Biosystems Inc director. Grant, award or other acquisition pursuant to Rule 16b-3
  
  
over a week ago at www.macroaxis.com         
Exercise or conversion by Makoto Kaneshiro of 64790 shares of WaferGen Bio subject to Rule 16b-3
Macroaxis News
Filed transaction by Wafergen Biosystems Inc director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
  
  
over a week ago at www.macroaxis.com         
Acquisition by Coradini Robert of 20000 shares of WaferGen Bio subject to Rule 16b-3
Macroaxis News
Filed transaction by Wafergen Biosystems Inc director. Grant, award or other acquisition pursuant to Rule 16b-3
  
  
over a week ago at www.macroaxis.com         
WaferGen Bio exotic insider transaction detected
Macroaxis News
Filed transaction by Wafergen Biosystems Inc director. Unconventional Insider trading
  
  
over a week ago at thefreenewsman.com         
Single Cell Genomics Market Industry Research Report 2017-2024 Added By DecisionDatabases
news
The Newsman Get full coverage
  
  
over two weeks ago at www.macroaxis.com         
Purchase by Shivji Alnoor of 1500 shares of WaferGen Bio
Macroaxis News
Filed transaction by Wafergen Biosystems Inc director. General open market or private purchase of non-derivative or derivative security
  
  
over two weeks ago at www.macroaxis.com         
Purchase by Joel Kanter of 183873 shares of WaferGen Bio
Macroaxis News
Filed transaction by Wafergen Biosystems Inc director. General open market or private purchase of non-derivative or derivative security
  
  
over two weeks ago at www.macroaxis.com         
WaferGen Bio exotic insider transaction detected
Macroaxis News
Filed transaction by Wafergen Biosystems Inc director. Unconventional Insider trading
  
  
over two weeks ago at www.macroaxis.com         
Exercise or conversion by Hariri Robert J of 1250 shares of WaferGen Bio subject to Rule 16b-3
Macroaxis News
Filed transaction by Wafergen Biosystems Inc director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
  
  
over three weeks ago at www.macroaxis.com         
WaferGen Bio exotic insider transaction detected
Macroaxis News
Filed transaction by Wafergen Biosystems Inc officer. Unconventional Insider trading
  
  
over three weeks ago at www.macroaxis.com         
WaferGen Bio exotic insider transaction detected
Macroaxis News
Filed transaction by Wafergen Biosystems Inc director. Unconventional Insider trading
  
  
over a month ago at www.macroaxis.com         
Purchase by Shivji Alnoor of 2870 shares of WaferGen Bio
Macroaxis News
Filed transaction by Wafergen Biosystems Inc director. General open market or private purchase of non-derivative or derivative security
  
  
over a month ago at www.macroaxis.com         
WaferGen Bio exotic insider transaction detected
Macroaxis News
Filed transaction by Wafergen Biosystems Inc director. Unconventional Insider trading
  
  
over a month ago at www.macroaxis.com         
WaferGen Bio exotic insider transaction detected
Macroaxis News
Filed transaction by Wafergen Biosystems Inc director. Unconventional Insider trading
  

Build Optimal Portfolios

Diversify Your Portfolio With WaferGen Bio systems
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add WaferGen Bio systems to your portfolio

Investors are also looking into

Acquisition by Mathewson David C of 9921 shares of U S subject to Rule 16b 3
July 18, 2018 for Mathewson David C
VerifyMe exotic insider transaction detected
July 18, 2018 for Laurence Blickman
Sale by Vittal Vasista of 1500 shares of Regenxbio
July 18, 2018 for Vittal Vasista
View All Premium Stories  

Performance against DOW

 Price Growth (%)  
      Timeline 
See also WaferGen Bio Hype Analysis, WaferGen Bio Correlation and WaferGen Bio Performance. Please also try Equity Valuation module to check real value of public entities based on technical and fundamental data.